Corporate News     29-Nov-24 Zomato successfully concludes QIP issue To allot 33.64 cr equity shares to eligible QIBs Zomato has approved the allotment of 33,64,73,755 equity shares at an issue price of Rs 252.62 per equity share (including a premium of Rs 251.62 per equity share), which is at a discount of 5% to the floor price of Rs 265.91 per equity share, to the eligible qualified institutional buyers. Previous News   Nifty June futures trade at premium  ( Market Commentary - Futures Market 03-Jun-25   16:12 )   Zomato consolidated net profit rises 388.89% in the September 2024 quarter  ( Results - Announcements 22-Oct-24   17:39 )   Nifty May futures trade at premium  ( Market Commentary - Futures Market 26-May-25   16:20 )   Stock Alert: Anant Raj, Zomato, Paytm, Allcargo Terminals, LIC  ( Market Commentary - Stock Alert 18-Feb-25   08:31 )   Zomato consolidated net profit rises 12550.00% in the June 2024 quarter  ( Results - Announcements 01-Aug-24   15:50 )   Nifty January futures trade at premium  ( Market Commentary - Futures Market 30-Dec-24   16:26 )   Zomato Q2 PAT soars to Rs 176 cr  ( Hot Pursuit - 22-Oct-24   17:55 )   Zomato allots 35.17 lakh equity shares under ESOP  ( Corporate News - 01-Aug-24   14:37 )   Zomato grants 3.18 crore stock options  ( Corporate News - 11-Jan-24   18:20 )   Zomato schedules board meeting  ( Corporate News - 07-May-24   14:13 )   Zomato spurts after reporting turnaround Q2 numbers  ( Hot Pursuit - 03-Nov-23   16:40 )	Other Stories   Board of HCL Technologies recommends Interim Dividend   14-Jul-25   17:52   Objectone Information Systems to conduct board meeting   14-Jul-25   17:50   JTEKT India AGM scheduled   14-Jul-25   17:50   Setco Automotive to discuss results   14-Jul-25   17:50   Saurashtra Cement to hold board meeting   14-Jul-25   17:49   John Cockerill India to table results   14-Jul-25   17:49   ATV Projects India to conduct board meeting   14-Jul-25   17:49   Shilchar Technologies schedules AGM   14-Jul-25   17:49   Sun Pharma settles litigation related to LEQSELVI™ with Incyte   14-Jul-25   16:53   Sun Pharmaceutical Industries launches LEQSELVI™ (deuruxolitinib) 8 mg tablets in United States   14-Jul-25   16:48
Back Top